Impact of Gaucher disease on COVID-19.
作者信息
Zimran Ari, Szer Jeff, Revel-Vilk Shoshana
机构信息
Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel.
Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
出版信息
Intern Med J. 2020 Jul;50(7):894-895. doi: 10.1111/imj.14894.
Abstract
摘要
相似文献
1
Impact of Gaucher disease on COVID-19.戈谢病对新冠病毒病的影响。
Intern Med J. 2020 Jul;50(7):894-895. doi: 10.1111/imj.14894.
2
Diabetes mellitus: Lessons from the COVID-19 pandemic.糖尿病：来自COVID-19大流行的经验教训。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):1-2. doi: 10.1016/j.hjc.2020.03.009. Epub 2020 May 18.
3
Biphasic Variation Over Time in Presenting Features of Patients With COVID-19.COVID-19患者临床表现随时间的双相变化
Pediatrics. 2020 Nov;146(5). doi: 10.1542/peds.2020-014902. Epub 2020 Sep 3.
4
Orthodox Judaism as a Risk Factor of Covid-19 in Israel.以色列东正教犹太教作为新冠病毒病的一个风险因素
Am J Med Sci. 2020 Sep;360(3):304. doi: 10.1016/j.amjms.2020.05.037. Epub 2020 Jun 1.
5
The COVID-19 pandemic.新型冠状病毒肺炎（COVID-19）疫情。
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388. doi: 10.1080/10408363.2020.1783198. Epub 2020 Jul 9.
6
Will antibody tests for the coronavirus really change everything?新冠病毒抗体检测真的会改变一切吗？
Nature. 2020 Apr;580(7805):571-572. doi: 10.1038/d41586-020-01115-z.
7
SARS-CoV-2 diagnostic testing in Africa: needs and challenges.非洲的新型冠状病毒肺炎诊断检测：需求与挑战
Pan Afr Med J. 2020 Apr 14;35(Suppl 2):4. doi: 10.11604/pamj.2020.35.4.22703. eCollection 2020.
8
The explosion of new coronavirus tests that could help to end the pandemic.新型冠状病毒检测的激增可能有助于终结这场大流行。
Nature. 2020 Jul;583(7817):506-509. doi: 10.1038/d41586-020-02140-8.
9
SARS-CoV-2 in the Employees of a Large University Hospital.一所大型大学医院员工中的新型冠状病毒2019（SARS-CoV-2）感染情况
Dtsch Arztebl Int. 2020 May 8;117(19):344-345. doi: 10.3238/arztebl.2020.0344.
10
A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.呼吁在新冠病毒背景下制定三级大流行公共卫生战略。
Rejuvenation Res. 2020 Aug;23(4):281-283. doi: 10.1089/rej.2020.2363. Epub 2020 Jun 24.
引用本文的文献
1
Impact of COVID-19 pandemic on healthcare delivery for lysosomal storage disorders at a tertiary care public hospital in Mumbai.COVID-19 大流行对孟买一家三级保健公立医院溶酶体贮积症医疗服务的影响。
J Postgrad Med. 2024 Jan-Mar;70(1):23-28. doi: 10.4103/jpgm.jpgm_705_23.
2
Lysosomal storage diseases in the era of COVID-19: a report of an Egyptian case of alpha-fucosidosis and a summary of the lysosomal storage diseases-COVID-19 relationship.新冠疫情时代的溶酶体贮积症：一例埃及α-岩藻糖苷酶缺乏症病例报告及溶酶体贮积症与新冠疫情关系综述
Egypt J Med Hum Genet. 2022;23(1):138. doi: 10.1186/s43042-022-00350-5. Epub 2022 Sep 15.
3
COVID-19 and Vaccination Status in Lysosomal Storage Diseases: A Single-Center Experience.溶酶体贮积症中的新冠病毒感染及疫苗接种状况：单中心经验
Turk Arch Pediatr. 2023 May;58(3):262-267. doi: 10.5152/TurkArchPediatr.2023.22233.
4
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.靶向 COVID-19 和戈谢病中的补体-鞘脂系统：一种新治疗策略的证据。
Int J Mol Sci. 2022 Nov 18;23(22):14340. doi: 10.3390/ijms232214340.
5
Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey.来自土耳其的黏多糖贮积症、戈谢病和庞贝病患者的真实世界患者免疫和 COVID-19 状况数据。
Arch Pediatr. 2022 Aug;29(6):415-423. doi: 10.1016/j.arcped.2022.05.003. Epub 2022 May 23.
6
COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases-Organizational Challenges from the Point of View of Healthcare Providers.2019冠状病毒病大流行与罕见遗传性代谢疾病和罕见自身炎症性疾病患者——医疗服务提供者视角下的组织挑战
J Clin Med. 2021 Oct 22;10(21):4862. doi: 10.3390/jcm10214862.
7
Gaucher disease - therapeutic aspects in Romania.戈谢病——罗马尼亚的治疗现状
Med Pharm Rep. 2021 Aug;94(Suppl No 1):S51-S53. doi: 10.15386/mpr-2230. Epub 2021 Aug 10.
8
The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system.戈谢病中 2019 年冠状病毒病感染的临床谱：大流行和破坏免疫系统的罕见病的双重影响。
Mol Genet Metab. 2022 Feb;135(2):115-121. doi: 10.1016/j.ymgme.2021.08.004. Epub 2021 Aug 13.
9
Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: A survey of healthcare professionals in the Fabry, Gaucher, and Hunter Outcome Survey registries.2019冠状病毒病大流行对溶酶体贮积症患者护理标准的影响：法布里病、戈谢病和亨特病结果调查登记处医疗保健专业人员的一项调查
Mol Genet Metab Rep. 2021 Sep;28:100788. doi: 10.1016/j.ymgmr.2021.100788. Epub 2021 Aug 4.
10
Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease.专家对新冠病毒疫苗接种的看法以及疫情对戈谢病患者的影响。
Br J Haematol. 2021 Oct;195(2):e135-e137. doi: 10.1111/bjh.17693. Epub 2021 Jul 5.
本文引用的文献
1
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
2
β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems.β-糖鞘脂作为炎症和免疫耐受的介质：生物系统随机性的表现。
Front Immunol. 2019 May 22;10:1143. doi: 10.3389/fimmu.2019.01143. eCollection 2019.
3
ACE phenotyping in Gaucher disease.戈谢氏病中的 ACE 表型。
Mol Genet Metab. 2018 Apr;123(4):501-510. doi: 10.1016/j.ymgme.2018.02.007. Epub 2018 Feb 17.
4
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.补体驱动葡萄糖神经酰胺积累和戈谢病中的组织炎症。
Nature. 2017 Mar 2;543(7643):108-112. doi: 10.1038/nature21368. Epub 2017 Feb 22.
Zotero 插件